1. Home
  2. DLY vs SIBN Comparison

DLY vs SIBN Comparison

Compare DLY & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DoubleLine Yield Opportunities Fund of Beneficial Interest

DLY

DoubleLine Yield Opportunities Fund of Beneficial Interest

HOLD

Current Price

$14.23

Market Cap

681.0M

Sector

Finance

ML Signal

HOLD

Logo SI-BONE Inc.

SIBN

SI-BONE Inc.

HOLD

Current Price

$12.98

Market Cap

622.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLY
SIBN
Founded
2019
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
681.0M
622.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
DLY
SIBN
Price
$14.23
$12.98
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$23.88
AVG Volume (30 Days)
184.7K
594.6K
Earning Date
01-01-0001
05-11-2026
Dividend Yield
8.93%
N/A
EPS Growth
N/A
41.33
EPS
N/A
N/A
Revenue
N/A
$67,301,000.00
Revenue This Year
N/A
$16.95
Revenue Next Year
N/A
$14.93
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.53
52 Week Low
$13.51
$11.80
52 Week High
$15.80
$21.89

Technical Indicators

Market Signals
Indicator
DLY
SIBN
Relative Strength Index (RSI) 52.75 46.08
Support Level $14.08 $11.98
Resistance Level $14.33 $13.49
Average True Range (ATR) 0.12 0.72
MACD 0.00 -0.00
Stochastic Oscillator 60.40 42.20

Price Performance

Historical Comparison
DLY
SIBN

About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest

DoubleLine Yield Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to seek a high level of total return, with an emphasis on current income. The company invests in debt securities and other income-producing investments of issuers anywhere in the world, including in emerging markets, and may invest in investments of any credit quality. Its investment portfolio comprises foreign corporate bonds, foreign government bonds, non-agency commercial mortgage-backed obligations, U.S. corporate bonds, collateralized loan obligations, and bank loans among other securities.

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Share on Social Networks: